Variant NM_000492.4:c.1355A>C


Variant details:
Name NM_000492.4:c.1355A>C
Protein name NP_000483.3:p.(Gln452Pro)
Genomic name (hg19) chr7:g.117188840A>C    UCSC    gnomAD
#Exon/intron exon 10
Legacy Name Q452P
Class VUS
Subclass VUS5
WT sequence ATTAATTTCAAGATAGAAAGAGGAC A GTTGTTGGCGGTTGCTGGATCCACT
Mutant sequence ATTAATTTCAAGATAGAAAGAGGAC C GTTGTTGGCGGTTGCTGGATCCACT


External sources:

Not found		dbSNP
rs397508193






Pathogenicity predictions:
AGVGD MAPP SIFT PPH2
C0 0.00011 0.02 0.777
VUS1 VUS5 VUS5 VUS4

Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing




No patient found in CFTR-NGS catalogue


3 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 3
CF 2
Pending (NBS) 1



Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
CF 5180heterozygoteCF-causing - Trans
CF 4439heterozygoteCF-causing - Trans
Pending (NBS) 3598heterozygoteCF-causing - Trans


Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.